Zypan Functional Dyspepsia

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Dyspepsia
Interventions
DIETARY_SUPPLEMENT

Zypan

The study product is a dietary supplement manufactured by Standard Process Inc (i.e., Zypan®). One serving (i.e., two tablets) contains a proprietary blend (595 mg) of the following: Betaine hydrochloride, bovine pancreas Cytosol™ extract, pepsin (1:10,000), pancreatin (3x), stearic acid (vegetable source), ammonium chloride, bovine spleen, and ovine spleen. Non active ingredients will include cellulose and calcium stearate. Participants will be instructed to take two tablets three times daily with meals

DIETARY_SUPPLEMENT

Placebo Comparator

The control supplement will not contain any of the active ingredients in Zypan® and will also be manufactured by Standard Process Inc. Two tablets will contain 435 mg of cellulose (42%), 288 mg rice bran powder (28%), 201 mg of calcium lactate powder (19.5%\*), 103 mg citric acid (10%), and 2.6 mg calcium stearate (0.25%)

Trial Locations (1)

97201

RECRUITING

Helfgott Research Institute, Portland

All Listed Sponsors
lead

National University of Natural Medicine

OTHER